Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Neglected Gut Microbiome: Fungi, Protozoa, and Bacteriophages in Inflammatory Bowel Disease
Gina L. Guzzo, Jane M. Andrews, Laura S. Weyrich
Inflammatory Bowel Diseases (2022) Vol. 28, Iss. 7, pp. 1112-1122
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

The role and mechanism of flavonoid herbal natural products in ulcerative colitis
Jia-Chen Xue, Shuo Yuan, Huan Meng, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 158, pp. 114086-114086
Open Access | Times Cited: 59
Colonization with two different Blastocystis subtypes in DSS-induced colitis mice is associated with strikingly different microbiome and pathological features
Lei Deng, Łukasz Wojciech, Chin Wen Png, et al.
Theranostics (2023) Vol. 13, Iss. 3, pp. 1165-1179
Open Access | Times Cited: 32
Gut Microbiome in Inflammatory Bowel Disease: Role in Pathogenesis, Dietary Modulation, and Colitis-Associated Colon Cancer
John Gubatan, Theresa Louise Boye, Michelle Temby, et al.
Microorganisms (2022) Vol. 10, Iss. 7, pp. 1371-1371
Open Access | Times Cited: 31
An inulin-type fructan isolated from Serratula chinensis alleviated the dextran sulfate sodium-induced colitis in mice through regulation of intestinal barrier and gut microbiota
Zhenwei Li, Qiuyi Wen, Jiaju Pi, et al.
Carbohydrate Polymers (2023) Vol. 320, pp. 121206-121206
Closed Access | Times Cited: 20
Probiotics in irritable bowel syndrome and inflammatory bowel disease: review of mechanisms and effectiveness
Daniel So, Eamonn M.M. Quigley, Kevin Whelan
Current Opinion in Gastroenterology (2023) Vol. 39, Iss. 2, pp. 103-109
Open Access | Times Cited: 16
The role of gut microbiome in inflammatory bowel disease diagnosis and prognosis
Jiaying Zheng, Qianru Sun, Jingwan Zhang, et al.
United European Gastroenterology Journal (2022) Vol. 10, Iss. 10, pp. 1091-1102
Open Access | Times Cited: 26
Using Drosophila melanogaster as a suitable platform for drug discovery from natural products in inflammatory bowel disease
Minghui Xiu, Yixuan Wang, Dan Yang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 23
Gut microbiome and mycobiome in inflammatory bowel disease patients with Clostridioides difficile infection
Si Yu, Xiaomeng Ge, Hui Xu, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 13
Intestinal Microbiota Dysbiosis Role and Bacterial Translocation as a Factor for Septic Risk
Ioannis Alexandros Charitos, Salvatore Scacco, Antonella Cotoia, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 2028-2028
Open Access
Lineage-specific microbial protein prediction enables large-scale exploration of protein ecology within the human gut
Matthias Schmitz, Nicholas J. Dimonaco, Thomas Clavel, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
The role of bacteriophage in inflammatory bowel disease and its therapeutic potential
Yang Xiao, Xinyu Yue, Xupeng Zhang, et al.
Critical Reviews in Microbiology (2025), pp. 1-15
Closed Access
Diversity of the microbiota communities found in the various regions of the intestinal tract in healthy individuals and inflammatory bowel diseases
Samuel Adefisoye Lawal, Athalia Voisin, Hana Olof, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 12
Diabetes and gut microbiome
K. Fliegerová, Tiziana Maria Mahayri, Hana Sechovcová, et al.
Frontiers in Microbiology (2025) Vol. 15
Open Access
Therapeutic Effects of Baicalin on Diseases Related to Gut–Brain Axis Dysfunctions
Qichao Hu, S. Hou, Baoyi Xiong, et al.
Molecules (2023) Vol. 28, Iss. 18, pp. 6501-6501
Open Access | Times Cited: 9
The Microbiome in Inflammatory Bowel Disease
Aranzazu Jauregui-Amezaga, Annemieke Smet
Journal of Clinical Medicine (2024) Vol. 13, Iss. 16, pp. 4622-4622
Open Access | Times Cited: 3
Investigating the Crime Scene—Molecular Signatures in Inflammatory Bowel Disease
Vibeke Andersen, Tue Bjerg Bennike, Corinna Bang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 11217-11217
Open Access | Times Cited: 7
Assessing fecal metaproteomics workflow and small protein recovery using DDA and DIA PASEF mass spectrometry
Angela Yee‐Moon Wang, Emily E.F. Fekete, Marybeth Creskey, et al.
Microbiome Research Reports (2024) Vol. 3, Iss. 3
Open Access | Times Cited: 2
Gut Microbiome as a Target of Intervention in Inflammatory Bowel Disease Pathogenesis and Therapy
‏Helal F. Hetta, Yasmin N. Ramadan, Ahmad A. Alharbi, et al.
Immuno (2024) Vol. 4, Iss. 4, pp. 400-425
Open Access | Times Cited: 2
Liubao insect tea polyphenols ameliorate DSS-induced experimental colitis by protecting intestinal barrier and regulating intestinal microbiota
Xinyu Feng, Yanwen Chen, Lina Luo, et al.
Food Chemistry (2024), pp. 142156-142156
Closed Access | Times Cited: 2
Effect of a Novel E3 Probiotics Formula on the Gut Microbiome in Atopic Dermatitis Patients: A Pilot Study
Yiwei Wang, Chi Tung Choy, Yufeng Lin, et al.
Biomedicines (2022) Vol. 10, Iss. 11, pp. 2904-2904
Open Access | Times Cited: 12
Individuals with Inflammatory Bowel Disease Have an Altered Gut Microbiome Composition of Fungi and Protozoa
Gina L. Guzzo, Murthy Mittinty, Bastien Llamas, et al.
Microorganisms (2022) Vol. 10, Iss. 10, pp. 1910-1910
Open Access | Times Cited: 10
Sargassum horneri Extract Ameliorates DSS-Induced Colitis through Modulation of mTOR Axis and Intestinal Microbiota
Yuri Im, Qunzhe Wang, Jumin Park, et al.
Applied Sciences (2023) Vol. 13, Iss. 3, pp. 1742-1742
Open Access | Times Cited: 5
Efficacy, Safety, and Concerns on Microbiota Modulation, Antibiotics, Probiotics, and Fecal Microbial Transplant for Inflammatory Bowel Disease and Other Gastrointestinal Conditions: Results from an International Survey
Tommaso Lorenzo Parigi, Sophie Vieujean, Kristine Paridaens, et al.
Microorganisms (2023) Vol. 11, Iss. 11, pp. 2806-2806
Open Access | Times Cited: 5
The Nonbacterial Microbiome: Fungal and Viral Contributions to the Preterm Infant Gut in Health and Disease
Adam Wilson, Brett Bogie, Hala Chaaban, et al.
Microorganisms (2023) Vol. 11, Iss. 4, pp. 909-909
Open Access | Times Cited: 4
Evaluation of Bacterial and Fungal Biomarkers for Differentiation and Prognosis of Patients with Inflammatory Bowel Disease
Hyuk Yoon, Sunghyouk Park, Yu Kyung Jun, et al.
Microorganisms (2023) Vol. 11, Iss. 12, pp. 2882-2882
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top